A Concerning Letter from Johnson & Johnson: TVM and Your Safety

As far back as 2007, Johnson & Johnson had been warned by the Food and Drug Administration (FDA) to discontinue marketing its Gynecare Prolift® transvaginal mesh (TVM) implant. The vaginal mesh is a device used to treat stress incontinence. Women who have this condition must contend with involuntarily bladder leakage brought about by weak uterine wall muscles. The urine discharge usually occurs when affected women sneeze, laugh or engage in a similar activity that uses these muscles in the body. Several manufacturers in addition to Johnson & Johnson have created vaginal meshes that have had serious side effects for women.

Continuing sale in spite of FDA warning

When Johnson & Johnson received the letter of reprimand from the FDA, it chose to ignore it and continued to sell these defective products for another nine months. When the company did finally discontinue producing and selling the Gynecare Prolift vaginal mesh implant, it was due to declining profits and not concern over women’s health risks. Unfortunately, the FDA lacked the power to sanction Johnson & Johnson for deliberately defying the mandates of its reprimand. However, the FDA did issue a warning to all users of the transvaginal mesh in June of 2011. This warning was prompted by complaints about numerous other manufacturers and different types of mesh slings.

Phillips Law Offices in Chicago is available to evaluate your claim if you have been injured by a defective transvaginal mesh product. There are several possibilities for claims, including manufacturing and design defects, failure by manufacturers and doctors to warn women of the risks, and more. Our team of experienced medical malpractice lawyers focuses on TVM cases, and we thoroughly research the facts in your case in order to determine whether a product liability lawsuit can be filed on your behalf. It is our goal to get you the compensation you need to cope with added medical expenses and unnecessary pain and suffering.

J&J Takes A Fall: Can the Public Put Their Trust in Major Pharmaceutical Companies?

For decades, Johnson & Johnson has been a corporate pillar in the pharmaceutical industry. After being hit with multiple product liability lawsuits, it appears that the company’s rock-solid foundation is crumbling. Although Johnson & Johnson grosses more than $65 billion annually, public confidence is dwindling. Recently, the company set aside $600 million to pay a massive fine. Media outlets report that the funds will cover settlements on multiple lawsuits. These suits were related to improperly marketing several pharmaceuticals and for bribing officials overseas.

Legal actions ongoing

In court, J&J is battling lawsuits regarding the antipsychotic medication Risperdal®. The company was sued for failing to publish information about the drug’s risks. In April 2012, the judge handling the case rendered a $1.1 billion verdict. A J&J spokeswoman said that the company would be appealing the ruling or seeking a new trial. On top of this massive award, J&J is facing lawsuits in other states. Judges for two of these cases ordered the company to pay nearly $600 million for similar allegations regarding Risperdal. J&J also paid $158 million to settle a Risperdal case in another state.

Johnson & Johnson is also facing lawsuits related to the medications Invega® and Natrecor®, which the company allegedly marketed for unapproved uses. Amid this never-ending stream of lawsuits, J&J has been charged with distributing kickbacks to artificially increase the sales of Risperdal to nursing home patients. If these allegations are true, Johnson & Johnson will be facing more penalties. The company’s new CEO, who was hired in late April 2012, has said publicly that the company is attempting to restore its image and to boost the confidence of consumers and investors.

These judgments should warn patients in Illinois who are currently taking any of these medications. Patients should discuss the potential risks with their doctor. If you believe you have been injured by a Johnson & Johnson medication, call the experienced medical product liability attorneys at the Phillips Law Offices in Chicago.